Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...

Metformin, a drug used to treat type 2 diabetes, could help deplete the viral reservoir and eliminate it entirely in people ...

Scientists have long been interested in metformin, a widely prescribed drug used to treat Type 2 diabetes, for its potential ...

Researchers at Université de Montréal's affiliated hospital research center, the CRCHUM, say the discovery could help lessen ...

Researchers at Université de Montréal’s affiliated hospital research centre, the CRCHUM, say the discovery could help lessen ...

The study, titled ‘Metformin decelerates aging clock in male monkeys’, was published in journal Cell on September 12.

The scientists have said much more research would be required before metformin can be approved as an anti-ageing compound in ...

A study from the Wellcome Sanger Institute shows metformin, a common diabetes medication, can slow the growth of precancerous ...

Researchers at Université de Montréal's affiliated hospital research centre, the CRCHUM, say the discovery could help lessen ...

Researchers investigated the ability of metformin to protect human cells and mice from DNA damage due to radiation exposure.

A common diabetes medication, metformin, slows the growth of precancerous cells in the esophagus while some metabolic ...

Monkeys that received metformin daily showed slower age-associated brain decline than did those not given the drug.